Amarin Stock News

Amarin Corporation plc (NASDAQ:AMRN) has a beta value of 2.11 and has seen 2.5 million shares traded in the last trading session. The company, currently valued at $1.44B, closed the last trade at $3.64 per share which meant it lost -$0.21 on the day or -5.45% during that session. The AMRN stock price is -154.12% Amarin Corporation plc Is A Buy Small Cap Stock: Analysts Read More »

Goldman Sachs Group Inc. reduced its position in shares of Amarin Co. plc (NASDAQ:AMRN) by 7.3% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 468,246 shares of the biopharmaceutical companys stock after selling 36,997 shares during the quarter. Goldman Sachs Group []

Amarin Co. plc (NASDAQ:AMRN) hit a new 52-week low on Monday . The stock traded as low as $3.83 and last traded at $3.85, with a volume of 14822 shares changing hands. The stock had previously closed at $3.90. AMRN has been the subject of several analyst reports. SVB Leerink restated a buy rating and []

Amarin Co. plc (NASDAQ:AMRN)s share price reached a new 52-week low during mid-day trading on Monday . The company traded as low as $3.83 and last traded at $3.85, with a volume of 14822 shares. The stock had previously closed at $3.90. A number of equities research analysts have commented on AMRN shares. Zacks Investment []

(PR-inside.com) NEW YORK, NY / ACCESSWIRE / November 22, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn''t require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below. Amarin Corporation Plc (NASDAQ:AMRN) CONTACT JAKUBOWITZ ABOUT AMRN:https://claimyourloss.com/securities/amarin-corporation-plc-loss-submission-form/?id=21438&from=1 Class Period : December ..

(PR-inside.com) NEW YORK, NY / ACCESSWIRE / November 19, 2021 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Amarin Corporation plc (NASDAQ:AMRN) between December 5, 2018 and June 21, 2021, inclusive (the "Class Period") of the important December 23, 2021 lead plaintiff deadline. SO WHAT: If you purchased Amarin securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Amarin class action, go to http://www.rosenlegal.com/cases-register-2186.html or call Phillip Kim, Esq. toll-free ..

Shares of Amarin Co. plc (NASDAQ:AMRN) have been assigned a consensus rating of Buy from the eight research firms that are currently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and four have issued a buy recommendation on the company. The []

(PR-inside.com) NEW YORK, NY / ACCESSWIRE / November 18, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn''t require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below. Amarin Corporation Plc (NASDAQ:AMRN)CONTACT JAKUBOWITZ ABOUT AMRN:https://claimyourloss.com/securities/amarin-corporation-plc-loss-submission-form/?id=21386&from=1Class Period: December 5, ..

Equities analysts predict that Amarin Co. plc (NASDAQ:AMRN) will post sales of $159.26 million for the current quarter, according to Zacks. Six analysts have issued estimates for Amarins earnings, with the highest sales estimate coming in at $192.80 million and the lowest estimate coming in at $139.60 million. Amarin posted sales of $167.25 million during []

Amarin is a pharmaceutical company offering products to improve cardiovascular health.

WHY: NEW YORK, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Amarin Corporation plc (NASDAQ: AMRN) between December 5, 2018 and June 21, 2021, inclusive (the Class Period) of the important December 23, 2021 lead plaintiff deadline .

Here's three penny stocks to add to your watchlist right now The post Here’s 3 Penny Stocks You Need to Know About Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennySt

Here's three penny stocks to add to your watchlist right now The post Here's 3 Penny Stocks You Need to Know About Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStock

Related Stocks: AMRN , KYMR , LXRX , CRNX , RAIN , VSTM , GLPG , AADI , TYRA , PNT , ALPN , ELEV , MRUS , RACA , FBRX , IMVT , CNTA ,